Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Rasna Therapeutics Inc. | ex322_6.htm |
| EX-32.1 - EXHIBIT 32.1 - Rasna Therapeutics Inc. | ex321_5.htm |
| EX-31.2 - EXHIBIT 31.2 - Rasna Therapeutics Inc. | ex312_4.htm |
| EX-31.1 - EXHIBIT 31.1 - Rasna Therapeutics Inc. | ex311_3.htm |
| EX-21 - EXHIBIT 21 - Rasna Therapeutics Inc. | ex21_1.htm |
| 10-K - 10-K - Rasna Therapeutics Inc. | rasp-20180930.htm |
Exhibit 24
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints, jointly and severally, Kunwar Shailubhai, his attorney-in-fact, each with full power of substitution and resubstitution, for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
|
Signature
|
|
Title(s)
|
|
Date
|
|
|
|
|||
|
Kunwar Shailubhai
|
|
Director, Chief Executive Officer
|
|
December 21, 2018
|
|
|
|
(Principal Executive Officer)
|
|
|
|
Tiziano Lazzaretti
|
|
Chief Financial Officer
|
|
December 21, 2018
|
|
|
(Principal Accounting and Financial Officer)
|
|
||
|
|
|
|||
|
John Brancaccio
|
|
Director
|
|
December 21, 2018
|
|
|
|
|||
|
Alessandro Padova
|
Director
|
December 21, 2018
|
||
|
John Alex Martin
|
|
Director
|
|
December 21, 2018
|